1. [O2–03–05]: AHA1 ACCELERATES HSP90 ATPASE ACTIVITY TO DRIVE TAU AGGREGATION. (1st July 2017) Authors: Shelton, Lindsey B.; Baker, Jeremy D.; Zheng, Dali; Ghosh, Suman; Blagg, Brian S.J.; Dickey, Chad A.; Blair, Laura J. Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 11 Page Start: P556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel C-terminal Hsp90 inhibitor KU758 synergizes efficacy in combination with BRAF or MEK inhibitors and targets drug-resistant pathways in BRAF-mutant melanomas. Issue 3 (June 2021) Authors: Sanchez, Jackee N.; Subramanian, Chitra; Chanda, Monica; Shanguan, Gary; Zhang, Nina; Wang, Ton; Timmermann, Barbara N.; Blagg, Brian S.J.; Cohen, Mark S. Journal: Melanoma research Issue: Volume 31:Issue 3(2021) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A succinct synthesis of (25R)-cholesta-5, 7-diene-3β, 26-diol from ergosterol. (3rd August 2022) Authors: Nannapaneni, Dharma Theja; Chinthapally, Kiran; Hatial, Ishita; Ashfeld, Brandon L.; Blagg, Brian S.J. Journal: Tetrahedron letters Issue: Volume 103(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Design, synthesis and biological evaluation of alkylamino biphenylamides as Hsp90 C-terminal inhibitors. Issue 2 (15th January 2017) Authors: Garg, Gaurav; Zhao, Huiping; Blagg, Brian S.J. Journal: Bioorganic & medicinal chemistry Issue: Volume 25:Issue 2(2017) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Disruptors of the Hsp90/Aha1 complex that reduce tau aggregation: Nonhuman/Lead optimization studies. (7th December 2020) Authors: Keegan, Bradley M; Koren, John; Blagg, Brian S.J. Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exploiting polarity and chirality to probe the Hsp90 C-terminus. Issue 12 (23rd July 2018) Authors: Forsberg, Leah K.; Davis, Rachel E.; Wimalasena, Virangika K.; Blagg, Brian S.J. Journal: Bioorganic & medicinal chemistry Issue: Volume 26:Issue 12(2018) Page Start: 3096 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity. Issue 22 (15th November 2019) Authors: Zhang, Zheng; Banerjee, Monimoy; Davis, Rachel E.; Blagg, Brian S.J. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 29:Issue 22(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modified biphenyl Hsp90 C-terminal inhibitors for the treatment of cancer. Issue 18 (15th September 2017) Authors: Forsberg, Leah K.; Liu, Weiya; Holzbeierlein, Jeffrey; Blagg, Brian S.J. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 27:Issue 18(2017) Page Start: 4514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reaction between harmaline and vanillin to produce dimeric scaffolds that exhibit anti-proliferative activity. (8th June 2021) Authors: Birar, Vishal C.; Zaid, Gene; Blagg, Brian S.J. Journal: Tetrahedron letters Issue: Volume 73(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Recent advances toward the development of Hsp90 C-terminal inhibitors. (15th January 2023) Authors: Amatya, Eva; Blagg, Brian S.J. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 80(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗